Andreani Guadalupe, Gagnon Dominic, Lodge Robert, Tremblay Michel J, Richard Dave
Infectious Disease Research Center, CHUL (CHUQ), Quebec City, Quebec, Canada.
J Vis Exp. 2012 Aug 15(66):e4166. doi: 10.3791/4166.
Plasmodium falciparum, the causative agent of the deadliest form of malaria, and human immunodeficiency virus type-1 (HIV-1) are among the most important health problems worldwide, being responsible for a total of 4 million deaths annually. Due to their extensive overlap in developing regions, especially Sub-Saharan Africa, co-infections with malaria and HIV-1 are common, but the interplay between the two diseases is poorly understood. Epidemiological reports have suggested that malarial infection transiently enhances HIV-1 replication and increases HIV-1 viral load in co-infected individuals. Because this viremia stays high for several weeks after treatment with antimalarials, this phenomenon could have an impact on disease progression and transmission. The cellular immunological mechanisms behind these observations have been studied only scarcely. The few in vitro studies investigating the impact of malaria on HIV-1 have demonstrated that exposure to soluble malarial antigens can increase HIV-1 infection and reactivation in immune cells. However, these studies used whole cell extracts of P. falciparum schizont stage parasites and peripheral blood mononuclear cells (PBMC), making it hard to decipher which malarial component(s) was responsible for the observed effects and what the target host cells were. Recent work has demonstrated that exposure of immature monocyte-derived dendritic cells to the malarial pigment hemozoin increased their ability to transfer HIV-1 to CD4+ T cells, but that it decreased HIV-1 infection of macrophages(8). To shed light on this complex process, a systematic analysis of the interactions between the malaria parasite and HIV-1 in different relevant human primary cell populations is critically needed. Several techniques for investigating the impact of HIV-1 on the phagocytosis of micro-organisms and the effect of such pathogens on HIV-1 replication have been described. We here present a method to investigate the effects of P. falciparum-infected erythrocytes on the replication of HIV-1 in human primary monocyte-derived macrophages. The impact of parasite exposure on HIV-1 transcriptional/translational events is monitored by using single cycle pseudotyped viruses in which a luciferase reporter gene has replaced the Env gene while the effect on the quantity of virus released by the infected macrophages is determined by measuring the HIV-1 capsid protein p24 by ELISA in cell supernatants.
恶性疟原虫是最致命形式疟疾的病原体,而人类免疫缺陷病毒1型(HIV-1)是全球最重要的健康问题之一,每年共导致400万人死亡。由于它们在发展中地区,特别是撒哈拉以南非洲地区广泛重叠,疟疾和HIV-1合并感染很常见,但这两种疾病之间的相互作用却知之甚少。流行病学报告表明,疟疾感染会短暂增强HIV-1复制,并增加合并感染个体的HIV-1病毒载量。由于在用抗疟药治疗后这种病毒血症会持续数周居高不下,这种现象可能会对疾病进展和传播产生影响。这些观察结果背后的细胞免疫机制很少被研究。少数研究疟疾对HIV-1影响的体外研究表明,暴露于可溶性疟原虫抗原可增加免疫细胞中HIV-1感染和再激活。然而,这些研究使用的是恶性疟原虫裂殖体阶段寄生虫和外周血单核细胞(PBMC)的全细胞提取物,因此很难解读是哪种疟原虫成分导致了观察到的效应以及靶宿主细胞是什么。最近的研究表明,未成熟单核细胞衍生的树突状细胞暴露于疟色素疟原虫血红素会增加其将HIV-1转移至CD4+T细胞的能力,但会降低巨噬细胞对HIV-1的感染(8)。为了阐明这一复杂过程,迫切需要对不同相关人类原代细胞群体中疟原虫与HIV-1之间的相互作用进行系统分析。已经描述了几种研究HIV-1对微生物吞噬作用的影响以及此类病原体对HIV-1复制的影响的技术。我们在此介绍一种研究恶性疟原虫感染的红细胞对人类原代单核细胞衍生巨噬细胞中HIV-1复制影响的方法。通过使用单周期假型病毒监测寄生虫暴露对HIV-1转录/翻译事件的影响,其中荧光素酶报告基因取代了Env基因,而通过ELISA测量细胞上清液中的HIV-1衣壳蛋白p24来确定对感染巨噬细胞释放病毒量的影响。